Table 1 Patients’ and tumor characteristics
From: Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma
| Â | All patients (n=30) | Locally advanced cholangiocarcinoma (n=24) | Local relapse of cholangiocarcinoma (n=6) |
|---|---|---|---|
Age at diagnosis (years) Median (range) | 68,3 (46–84) | 71,2 (46–84) | 59,6 (50–68) |
Gender | Â | Â | Â |
Male | 19 (63%) | 14 (58%) | 5 (83%) |
Female | 11 (37%) | 10 (42%) | 1 (17%) |
Performance status | Â | Â | Â |
0 | 1 (3%) | 1 (4%) | 0 |
1 | 21 (70%) | 15 (63%) | 6 (100%) |
2 | 5 (17%) | 5 (21%) | 0 |
3 | 3 (10%) | 3 (12%) | 0 |
Tumor size (mm) Mean (range) | - | 36 (12–83) | - |
Location | Â | Â | Â |
Hilar | - | 16 (67%) | - |
Intermediate | - | 2 (8%) | - |
Distal | - | 6 (25%) | - |
T (TNM classification) | Â | Â | Â |
T1 | - | 1 (4%) | - |
T2 | - | 2 (8%) | - |
T3 | - | 12 (50%) | - |
T4 | - | 6 (25%) | - |
ND | - | 3 (13%) | - |
N (TNM classification) | Â | Â | Â |
N0 | - | 11 (46%) | - |
N1 | - | 11 (46%) | - |
ND | - | 2 (8%) | - |
Bismuth classification | Â | Â | Â |
I | - | 9 (38%) | - |
III | - | 4 (16%) | - |
IV | - | 11 (46%) | - |
Follow-up (months) | Â | Â | Â |
Median (range) | 61,7 (5–180) | 54,8 (5–131) | 117 (58–180) |
Alive at last follow-up: N | 2 | 2 | 0 |